Ly Mee Yu

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. pmc Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature review
    Ly Mee Yu
    Centre for Statistics in Medicine, University of Oxford, Wolfson College Annexe, Oxford, UK
    Trials 11:59. 2010
  2. doi Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study
    Ameneh Khatami
    Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre and Department of Paediatrics, University of Oxford, Oxford, United Kingdom
    Pediatr Infect Dis J 31:1069-73. 2012
  3. pmc Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months
    Fiona McQuaid
    Oxford Vaccine Group, Department of Paediatrics McQuaid, Snape, John, Kelly, Robinson, Pollard, and Nuffield Department of Primary Care Health Sciences Yu, University of Oxford, Oxford, UK Oxford Biomedical Research Centre McQuaid, Snape, John, Kelly, Robinson, Pollard, National Institute for Health Research, Oxford, UK Novartis Vaccines and Diagnostics S r l Toneatto, Siena, Italy Novartis Pharma BV D Agostino, Amsterdam, Netherlands Novartis Vaccines and Diagnostics Inc Dull, Cambridge, Mass
    CMAJ 187:E215-23. 2015
  4. doi Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of preschool booster doses: a follow-on study to a randomized clinical trial
    Matthew D Snape
    From the Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom Novartis Vaccines and Diagnostics Srl, Siena, Italy and Novartis Vaccines and Diagnostics Inc, Cambridge, MA
    Pediatr Infect Dis J 32:1116-21. 2013
  5. doi Effects of on-pump and off-pump surgery in the Arterial Revascularization Trial
    David P Taggart
    Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Oxford, UK
    Eur J Cardiothorac Surg 47:1059-65. 2015
  6. pmc Efficacy of cognitive behavioural therapy for sleep improvement in patients with persistent delusions and hallucinations (BEST): a prospective, assessor-blind, randomised controlled pilot trial
    Daniel Freeman
    Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK Electronic address
    Lancet Psychiatry 2:975-83. 2015
  7. doi Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants
    Ameneh Khatami
    Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre and Department of Paediatrics, University of Oxford, Oxford, United Kingdom
    Pediatr Infect Dis J 32:675-81. 2013
  8. pmc Impact of peer review on reports of randomised trials published in open peer review journals: retrospective before and after study
    Sally Hopewell
    Centre for Statistics in Medicine, University of Oxford, UK Centre d Epidémiologie Clinique, Universite Paris Descartes, Inserm U1153, France
    BMJ 349:g4145. 2014
  9. pmc External validation of multivariable prediction models: a systematic review of methodological conduct and reporting
    Gary S Collins
    Centre for Statistics in Medicine, Botnar Research Centre, University of Oxford, Windmill Road, Oxford OX3 7LD, UK
    BMC Med Res Methodol 14:40. 2014
  10. doi Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine
    Geraldine Blanchard-Rohner
    Oxford Vaccine Group and the NIHR Oxford Biomedical Research Centre, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, UK
    Vaccine 30:4153-9. 2012

Detail Information

Publications23

  1. pmc Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature review
    Ly Mee Yu
    Centre for Statistics in Medicine, University of Oxford, Wolfson College Annexe, Oxford, UK
    Trials 11:59. 2010
    ..To evaluate the use and reporting of adjusted analysis in randomised controlled trials (RCTs) and compare the quality of reporting before and after the revision of the CONSORT Statement in 2001...
  2. doi Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study
    Ameneh Khatami
    Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre and Department of Paediatrics, University of Oxford, Oxford, United Kingdom
    Pediatr Infect Dis J 31:1069-73. 2012
    ..We evaluated whether these differences persisted to later childhood, following a preschool booster of DTaP-IPV at 3½ years of age...
  3. pmc Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months
    Fiona McQuaid
    Oxford Vaccine Group, Department of Paediatrics McQuaid, Snape, John, Kelly, Robinson, Pollard, and Nuffield Department of Primary Care Health Sciences Yu, University of Oxford, Oxford, UK Oxford Biomedical Research Centre McQuaid, Snape, John, Kelly, Robinson, Pollard, National Institute for Health Research, Oxford, UK Novartis Vaccines and Diagnostics S r l Toneatto, Siena, Italy Novartis Pharma BV D Agostino, Amsterdam, Netherlands Novartis Vaccines and Diagnostics Inc Dull, Cambridge, Mass
    CMAJ 187:E215-23. 2015
    ..We investigated the persistence of antibodies in 5-year-old children 18-20 months after their last dose (at about 3.5 years of age)...
  4. doi Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of preschool booster doses: a follow-on study to a randomized clinical trial
    Matthew D Snape
    From the Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom Novartis Vaccines and Diagnostics Srl, Siena, Italy and Novartis Vaccines and Diagnostics Inc, Cambridge, MA
    Pediatr Infect Dis J 32:1116-21. 2013
    ..We studied persistence of this response and the response to a booster dose of vaccine...
  5. doi Effects of on-pump and off-pump surgery in the Arterial Revascularization Trial
    David P Taggart
    Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Oxford, UK
    Eur J Cardiothorac Surg 47:1059-65. 2015
    ..The objective of this post hoc analysis was to evaluate the surgical process and 1-year outcomes for surgery performed on-pump compared with off-pump...
  6. pmc Efficacy of cognitive behavioural therapy for sleep improvement in patients with persistent delusions and hallucinations (BEST): a prospective, assessor-blind, randomised controlled pilot trial
    Daniel Freeman
    Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK Electronic address
    Lancet Psychiatry 2:975-83. 2015
    ..We aimed to pilot procedures for a randomised trial testing CBT for sleep problems in patients with current psychotic experiences, and to provide a preliminary assessment of potential benefit...
  7. doi Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants
    Ameneh Khatami
    Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre and Department of Paediatrics, University of Oxford, Oxford, United Kingdom
    Pediatr Infect Dis J 32:675-81. 2013
    ..To test for immunologic noninferiority of antibody responses to Hib and MenC using a 6-in-1 combination vaccine (DTPa-IPV/Hib-MenC-TT) compared with DTPa-IPV-Hib plus MenC-CRM197, before and after a 12-month Hib-MenC-TT booster...
  8. pmc Impact of peer review on reports of randomised trials published in open peer review journals: retrospective before and after study
    Sally Hopewell
    Centre for Statistics in Medicine, University of Oxford, UK Centre d Epidémiologie Clinique, Universite Paris Descartes, Inserm U1153, France
    BMJ 349:g4145. 2014
    ..To investigate the effectiveness of open peer review as a mechanism to improve the reporting of randomised trials published in biomedical journals...
  9. pmc External validation of multivariable prediction models: a systematic review of methodological conduct and reporting
    Gary S Collins
    Centre for Statistics in Medicine, Botnar Research Centre, University of Oxford, Windmill Road, Oxford OX3 7LD, UK
    BMC Med Res Methodol 14:40. 2014
    ..We critically appraised the methodological conduct and reporting of external validation studies of multivariable prediction models...
  10. doi Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine
    Geraldine Blanchard-Rohner
    Oxford Vaccine Group and the NIHR Oxford Biomedical Research Centre, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, UK
    Vaccine 30:4153-9. 2012
    ..That an inhibitory effect of baseline antibody cannot be assumed a priori is supported by observations in animal models, which show that baseline antibody can both suppress or enhance the antibody response to a specific antigen...
  11. pmc Reporting of participant flow diagrams in published reports of randomized trials
    Sally Hopewell
    Centre for Statistics in Medicine, University of Oxford, Wolfson College, Linton Road, Oxford, UK
    Trials 12:253. 2011
    ..We assessed the type and completeness of information reported in CONSORT (Consolidated Standards of Reporting Trials) flow diagrams published in current reports of randomized trials...
  12. doi A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods
    Gary S Collins
    Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford, Linton Road, Oxford OX2 6UD, UK
    J Clin Epidemiol 66:268-77. 2013
    ....
  13. doi Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations
    Ameneh Khatami
    Oxford Vaccine Group, Department of Paediatrics, University of Oxford, UK
    Vaccine 30:2831-8. 2012
    ..We evaluated the persistence of bactericidal antibodies through early childhood, following infant immunisation with varying schedules of MenACWY-CRM(197) vaccine...
  14. doi Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial
    Nicoletta Gossger
    Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre and Department of Paediatrics, University of Oxford, Oxford, United Kingdom
    JAMA 307:573-82. 2012
    ..In the absence of an effective vaccine, serogroup B Neisseria meningitidis (MenB) remains a major cause of invasive disease in early childhood in developed countries...
  15. doi Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial
    John R Geddes
    Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK
    Lancet Psychiatry 3:31-9. 2016
    ..We aimed to determine if combination therapy with quetiapine plus lamotrigine leads to greater improvement in depressive symptoms over 12 weeks than quetiapine monotherapy plus lamotrigine placebo...
  16. pmc Association between population prevalence of smoking and incidence of meningococcal disease in Norway, Sweden, Denmark and the Netherlands between 1975 and 2009: a population-based time series analysis
    Gunnstein Norheim
    Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK
    BMJ Open 4:e003312. 2014
    ..To investigate the relationship between the prevalence of smoking in the population and incidence of invasive meningococcal disease (IMD) among children under 5 years of age...
  17. pmc Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells
    Elizabeth A Clutterbuck
    Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
    J Infect Dis 205:1408-16. 2012
    ..It is not known whether pneumococcal polysaccharide-protein conjugated vaccines (PCV), although highly effective in infants, offer any immunological advantages over 23vP in adults...
  18. pmc The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed
    Sally Hopewell
    Centre for Statistics in Medicine, University of Oxford, Linton Road, Oxford OX2 6UD
    BMJ 340:c723. 2010
    ....
  19. pmc Effects of cognitive behavioural therapy for insomnia on the mental health of university students: study protocol for a randomized controlled trial
    Daniel Freeman
    Sleep and Circadian Neuroscience Institute, Department of Psychiatry, University of Oxford, Warneford Hospital, Warneford Lane, Oxford, OX3 7JX, UK
    Trials 16:236. 2015
    ..The theoretical links will be substantiated by a planned mediation analysis. Improvements in a number of other mental health outcomes are also predicted...
  20. pmc The effects of using cognitive behavioural therapy to improve sleep for patients with delusions and hallucinations (the BEST study): study protocol for a randomized controlled trial
    Daniel Freeman
    Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK
    Trials 14:214. 2013
    ..The clear next step is a pilot randomized controlled test. The clinical aim is to test whether CBT-I can reduce both insomnia and psychotic symptoms. The trial will inform decisions for a definitive large-scale evaluation...
  21. pmc Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting
    Gary S Collins
    Centre for Statistics in Medicine, University of Oxford, Wolfson College Annexe, Oxford, OX2 6UD, UK
    BMC Med 9:103. 2011
    ....
  22. doi Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine
    Philip C S de Whalley
    Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom
    Pediatr Infect Dis J 30:e203-8. 2011
    ..Adolescents are at particular risk from meningococcal disease, therefore they might benefit from a booster dose of vaccine. The duration of serologic response to such a booster in adolescents is unknown...
  23. doi Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART)
    David P Taggart
    Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK
    Eur Heart J 31:2470-81. 2010
    ..The Arterial Revascularisation Trial (ART) is a randomized trial of BIMA vs. SIMA, with a primary outcome of survival at 10 years. This paper reports mortality, morbidity, and resource use data at 1 year...